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Asthma, or acute reversible obstructive airways
disease (ROAD), is a major respiratory disease af
fecting approximately eight million people in the
United States. The disease is characterized by attacks
of wheezing dyspnea with coughing and sputum pro
duction. Although most adult patients who have the
disease demonstrate either bronchospastic episodes
during childhood or will have repeated episodes of
respiratory infection, upper and lower or both during
early years, some patients do begin only in later life,
that is, adult onset asthma. All of these patients usu
ally have no symptoms or signs during interval peri
ods, but with proper stimuli will demonstrate airways
obstruction.
The pathogenesis and pathology of asthma are
located in the airways where there is bronchospasm
from contraction of the circumairway smooth
muscle, mucosal edema, and excessive 111 ucous pro
duction, all leading to narrowing of the airway lu
men. These processes are initiated by the release of
chemical medicators from pulmonary mast cells by a
variety of stimuli. The abnormal response of the asth
matic bronchus may be caused by an immune reac
tion involving lgE, by infection, by certain physical
factors including exercise and cold temperature, as
well as by a combination of these factors and prob
ably other unknown factors. Patients with asthma
respond to minimal stimuli with increase in airways
resistance indicating the presence of increased airway
tone or ease of provocation-"twitchy airways." This
is indicated by the smaller dose of known airway
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constrictors necessary to produce bronchoconstric
tion in an asthmatic than in a normal person. This
has led to the theory of partial beta blockade. The
sympathetic beta two receptors located in the air
ways are bronchodilating. Inhibition or blockade
of these receptors results in bronchoconstriction, thus
suggesting a partial beta blockade in patients with
asthma. Alpha sympathetic stimulation also leads to
bronchoconstriction. This knowledge has led to the
better understanding of the biochemical mechanisms
of asthma and to drug therapy. Superficially,
bronchodilation is medicated primarily by increases
in 3, 5 cyclic AMP. Cyclic AMP production is
increased by beta agonists, for example, ephedrine,
isoproterenol, isoetharine, and others. Its breakdown
is inhibited by methylxanthines, for example, ami
nophylline. Therefore, it is very rational to treat asth
matics with both of these classes of drugs at the
same time (1-4).
The diagnosis of ROAD is not difficult in the
usual case. However, particularly in older adults, dif
ficulty in separating other chronic airways disease,
especially chronic bronchitis, becomes a problem.
These two conditions frequently occur together and
should be separated, according to the purist. From a
practical therapeutic standpoint, it makes little differ
ence, except from a prognostic standpoint, since
chronic bronchitis tends to be a progressive disease
and asthma may not be.
The management of ROAD can be separated
into three phases: I) Outpatient, 2) Emergency Room,
and 3) Inpatient. The objective of therapy should be
to avoid. if at all possible. phases two and three.
Outpatient management should include a dili
gent search for inciting causes of episodes,
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particularly those avoidable irritants which must
be isolated and removed from the patient's en
vironment. This must include a thorough history to
evaluate the problems of allergy, for example. pre
vious history of allergic reactions. eczema as a child.
recurring rhinitis, hayfever, and other factors. On
physical examination. the presence of congested,
bluish, nasal mucous membranes or nasal polyps
suggests allergy. Eosinophilia in nasal or sputum
smears or peripheral blood smears, additionally.
suggests allergy and should be evaluated in all
patients with ROAD. Since many parasitic diseases
will have pulmonary involvement, the stools of
patients with peripheral eosinophilia should be eval
uated for ova and parasites. Most people spend more
time in their bedroom than in any other room, thus
attempts should be made to keep this room as dust
and antigen-free as possible. Therefore, nonallergic
bed covers and pillows should be used. overstuffed
furniture, wool rugs, and draperies should be re
moved. The room should be cleaned in the morning
to allow dust to settle before night. No animals
should be allowed in the bedroom. I believe that all
patients who have a suggestion of allergy should be
evaluated by an allergist and desensitized if indicated.
The drug therapy of ROAD should include both
sympathomimetics, (epinephrine, ephedrine, terbuta
line, metaproterenol, and others) plus xanthines
(aminophylline) for the above mentioned reasons.
Depending upon the severity of the difficulty. the
dosage of these drugs will need to be varied. Some
patients will require drugs intermittently, some con
tinuously. Since much of the problem is caused by
excessive mucous plugging of airways (7), and
antihistamines have a drying effect on mucous, ten
ding to make its removal more difficult, I prefer not
to use these drugs. Instead, these patients should be
encouraged to force hydrate themselves to keep secre
tions in as loose a state as possible. The use of anti
biotics is predicated on the presence of infection
which is best assessed by evaluation of the sputum,
both in wet preparation and gram stains, to look for
polys and pathogenic bacteria as well as eosinophils,
Charcot-Leyden crystals, and Curschmann's spirals.
Adrenal steroids should be used as the last drug when
other drugs have failed or in patients who have been
known to require steroids previously. Another drug
which has outpatient application is cromolyn so
dium. This drug has no effect in the acute attack and
should be used only to prevent attacks. It should be
tried in patients who have frequent bronchospastic
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episodes or who require continuous steroids to avoid
attacks. It must be administered four times daily
and should be given for several weeks to assess its
therapeutic value. The combination of the above
modalities should be adequate to control 80% to 90%
of all patients with ROAD.
Most patients who arrive in the Emergency
Room because the above regimen has failed or be
cause they have not had proper medical supervision
will respond to parenteral bronchodilators. However,
arterial blood gases should be measured to evaluate
the need for oxygen therapy. Eighty percent or more
of these patients will have mild hypoxemia and will
be hyperventilating, (low PaCO,) (5). If the pCO, is
normal or elevated, this indicates a more severe state
and such an individual should be considered under
phase three (6). Either subcutaneous epinephrine
0.3 cc, I: I000 aqueous epinephrine or terbutaline
0.25 mg should be given initially and may be repeated
in 15 to 30 minutes if needed. Obviously, patients
with cardiac disease (arrhythmia, angina, hyperten
sion. and others) are at great risk under these condi
tions. particularly if very hypoxemic, and must be
monitored carefully. If this is ineffective, intravenous
aminophylline should be used, 5 to 6 mg/kg body
weight, no more rapidly than 50 mg/min ( 10).
Aerosolized sympathomimetics may be used
also. or instead of parenteral drug. Again. the car
diac rate, rhythm, and blood pressure must be mon
itored since there is a significant systemic effect from
most of these drugs.
Most of these patients will be quite anxious and
the temptation to sedate them is great. They are
anxious because they are hypoxemic and dyspneic.
Additionally, most bronchodilators have central ef
fects which are stimulatory, increasing anxiety. Al
though some patients can trigger bronchospastic epi
sodes by anxiety, the use of tranquilizers or sedatives
is exceedingly dangerous, thus these drugs should not
be used. Patients with ROAD do not thrive in the
average emergency room environment. They should
be kept in a quiet area under constant supervision
and frequently reassured that they are receiving ade
quate care. If this, plus the above therapy is
administered, most of these patients will not require
admission. Several series have demonstrated that
only 2% to 5% of all patients will require admission.
The inpatient management of ROAD, phase
three, covers only a very small percentage of the
total population of patients at risk; however, if im
properly treated during this phase, the mortality is
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significant. The question is frequently asked as to
which patients should be admitted. The following
guidelines are useful:
I. All patients with high normal or elevated
PaCO,'s or low pH's, that is, less than 7.30,
need admission.
2. Patients with forced expiratory volume in one
second (FEY,) of less than 0.5 liters. FEV,'s
are sometimes difficult to measure and equip
ment is not always readily available, there
fore, alternate mechanisms to assess function
are needed. McFadden (9) demonstrated that
intercostal retraction related well to severe
mechanical obstruction and usually dis
appeared with FEV,'s greater than one liter.
Rebuck (8) has shown that pulsus para
doxicus of greater than 10 to 12 mm Hg
systolic blood pressure correlated well with
severe reduction in FEY,. Thus. the presence
of retractions and paradox should indicate
admission.
3. Patients with prolonged attacks, that is.
greater than 12 hours.
4. Patients demonstrating physical exhaustion.
5. Patients who fail to respond to phase two
measures within four to six hours.
6. Patients with falling Pa02 and rising PaC02
with emergency room management.
Once the decision to admit has been made, the
severity of the situation will dictate the best area of
the hospital for therapy. Generally, the ICU should
be considered as the desired location. The scope of
intensive care management is beyond this paper, but
several points should be made (2. 4, 6 ):
I. No sedatives.
2. Continuous 0, therapy (best given by nasal
cannula) to maintain Pa02, 60 to 70 mm Hg.
3. Frequent arterial gases until the patient is
clearly better.
4. Continuous aminophylline 1.V. (0.9
mg/kg/hr) after an initial loading dose (5.6
mg/kg/20 min).
5. Inhaled or subcutaneous sympathomimetic
drugs, or both, using monitoring of cardiac
rate, rhythm, and blood pressure as the con
trolling factors.
6. ECG monitoring.
7. Adequate hydration, since these patients are
almost invariably dehydrated, which causes
difficulty in clearing trachea-bronchial secre
tions. This initially will have to be intraven-

ous. Various estimates of fluid deficit have
been made; however, good data is not
available. Inpatients with normal cardio
vascular-renal mechanisms should have fluid
therapy until their secretions are thin and
easily cleared.
8. Humidity therapy with warm moist air, if
tolerated, will help to loosen secretions.
9. Corticosteroid therapy is a major portion
of the therapy and must be given in
pharmacologic doses. Methylprednisolone,
250 mg, I.V. Q4h, has been very valuable in
this area. It is preferred because of less miner
alocorticoid effect, plus a longer half life than
hydrocortisone. There are other less well
defined reasons for·the use of this drug.
The other frequently asked question is, when
should these patients be placed on continuous ven
tilator support1 There are several guidelines which
are used by most physicians caring for numbers of
these patients. and these guidelines are based primar
ily on arterial blood gas studies. If the PaCO, begins
to rise above the normal range (greater than 45 mm
Hg) or the pH falls below 7.30 with the above pro
gram, these patients are at great risk for respiratory
and cardiac arrest, therefore, we electively intubate
and assist these patients. Marked depression in the
level of consciousness from severe fatigue indicates
the need for ventilatory assistance. Continued unre
mitting bronchospasm with optimal therapy should
also be considered an indication for ventilatory as
sistance.
In summary, reversible obstructive airways
disease (ROAD) is a common respiratory problem.
Proper education and outpatient management will
almost always provide adequate care. However, some
patients require more active therapy in emergency
rooms or hospitals. Since almost all patients, prop
erly treated, will survive to return to productive life, a
well-planned, aggressive therapeutic approach is
needed as outlined in this paper.
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